BSX — Boston Scientific Corporation Common Stock
Session close: $42.69. Regular-session share volume: 29,126,628. Change from previous close: +0.61%.
News sources
Company news RBC Capital Maintains Outperform on Boston Scientific, Lowers Price Target to $52 · Company news Citigroup Maintains Neutral on Boston Scientific, Lowers Price Target to $44 · Company news Boston Scientific (BSX) Wins FDA Clearances, Starts Elite AF Trial And Expands AI Push · Company news Leerink Partners Maintains Outperform on Boston Scientific, Lowers Price Target to $50 · Company news UBS Maintains Buy on Boston Scientific, Lowers Price Target to $57 · Company news Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45 · Company news Analysts Downgrade Boston Scientific Following Q3 Earnings · Company news BSX Q3 Earnings Call Flags Growth Challenges Through 2027 · Company news These Analysts Revise Their Forecasts On Boston Scientific After Q3 Results · Company news Baird Maintains Outperform on Boston Scientific, Raises Price Target to $51 · Company news Boston Scientific (BSX) Could Be 27% Below Fair Value After Earnings Guidance Cut · Company news Boston Scientific (BSX) Stock Sinks As Q3 Results Deepen Margin Concerns · Company news Why Boston Scientific (BSX) shares are plunging today · Company news Boston Scientific Crashes As Cybersecurity Attack Weighs On Guide